Timothy Chevassut
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
-
- Epigenetics and DNA Methylation 10
- Protein Degradation and Inhibitors 8
- Histone Deacetylase Inhibitors Research 4
- Cancer-related gene regulation 3
- Hematology 22
- Acute Myeloid Leukemia Research 11
- Multiple Myeloma Research and Treatments 9
- Co-authors
- Helen Stewart (7 shared papers)Bernard Ramsahoye (2 shared papers)Gillian A. Horne (4 shared papers)Lesley M. Forrester (1 shared paper)Nick Gilbert (1 shared paper)John Ansell (1 shared paper)Melany Jackson (1 shared paper)Sarah F. Newbury (5 shared papers)
- Journals
- Clinical Medicine (3 papers)British Journal of Haematology (2 papers)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (1 paper)Experimental Hematology (1 paper)BioMed Research International (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Timothy Chevassut
42 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 90
- Hematology 405
- Cancer Research 168
- Molecular Biology 824
- Genetics 88
- Immunology 100
Countries citing papers authored by Timothy Chevassut
This map shows the geographic impact of Timothy Chevassut's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Chevassut with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Chevassut more than expected).
Fields of papers citing papers by Timothy Chevassut
This network shows the impact of papers produced by Timothy Chevassut. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Chevassut. The network helps show where Timothy Chevassut may publish in the future.
Co-authors
The 25 scholars most cited alongside Timothy Chevassut, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 251 | |
| 2 | 2012 | 110 | |
| 3 | 2016 | 95 | |
| 4 | 2014 | 78 | |
| 5 | 2014 | 76 | |
| 6 | 2013 | 70 | |
| 7 | 2020 | 56 | |
| 8 | 2018 | 55 | |
| 9 | 2015 | 46 | |
| 10 | 2020 | 41 | |
| 11 | 2014 | 41 | |
| 12 | 2014 | 40 | |
| 13 | 2017 | 31 | |
| 14 | 2015 | 31 | |
| 15 | 2022 | 27 | |
| 16 | 2013 | 23 | |
| 17 | 2017 | 23 | |
| 18 | 2012 | 19 | |
| 19 | 2018 | 15 | |
| 20 | 2010 | 15 |
About Timothy Chevassut
Timothy Chevassut is a scholar working on Molecular Biology, Hematology, Genetics, Emergency Medicine and Cancer Research, having authored 43 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Epigenetics and DNA Methylation (10 papers), Multiple Myeloma Research and Treatments (9 papers), Protein Degradation and Inhibitors (8 papers), Hematological disorders and diagnostics (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Cancer-related gene regulation (3 papers). The work is most often cited by research in Hematology (405 citations), Cancer Research (168 citations), Molecular Biology (824 citations), Genetics (88 citations) and Immunology (100 citations). Timothy Chevassut has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Helen Stewart, Bernard Ramsahoye, Gillian A. Horne, Lesley M. Forrester, Nick Gilbert, John Ansell, Melany Jackson, Sarah F. Newbury, Eleni E Ladikou and Andrea Pepper. Their work appears in journals such as Clinical Medicine, British Journal of Haematology, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Experimental Hematology and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.